Pathology and Lab Medicine
17-32 of 34
Wenxin Xu, MD
Sandy Srinivas, MD
Ignacio Duran, MD
Wenxin Xu, MD
- MinuteCE®
Emerging targeted therapy combination strategies in genitourinary malignancies
1.25 program creditsIgnacio Duran, MD
- MinuteCE®
Emerging immunotherapy combination strategies in genitourinary malignancies
1.25 program creditsSandy Srinivas, MD
Ignacio Duran, MD
Wenxin Xu, MD
Hope S. Rugo, MD, FASCO
Nadia Harbeck, MD, PhD
- MinuteCE®
Endpoints in Adjuvant Breast Cancer Trials: Implications for Clinical Practice
1.25 program creditsHope S. Rugo, MD, FASCO
Nadia Harbeck, MD, PhD
Nadia Harbeck, MD, PhD
Hope S. Rugo, MD, FASCO
Nadia Harbeck, MD, PhD
- MinuteCE®
Differentiating Safety Profiles of CDK4/6 Inhibitor Combination Regimens
1.25 program creditsHope S. Rugo, MD, FASCO
Nadia Harbeck, MD, PhD
Nadia Harbeck, MD, PhD
Hope S. Rugo, MD, FASCO
Nadia Harbeck, MD, PhD
Nadia Harbeck, MD, PhD
Hope S. Rugo, MD, FASCO
Nadia Harbeck, MD, PhD
Jacob Sands, MD
Kathleen Fenn, MD
Oudai Hassan, MD
Jacob Sands, MD
Lori Pierce, MD, FASTRO, FASCO
